Expert Chat: A Conversation with Dr. Nicole White
October 7, 2021 From mom of four to Down syndrome researcher. Research Spotlight sat with…
CapetivateOctober 7, 2021
LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage
LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage
August 18, 2021 LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The…
A New Perspective on The Aduhelm Controversy
People with Down syndrome live longer and more independently now than ever before. Supported by…
CapetivateJuly 15, 2021
LuMind IDSC signs on to NTG statement re: Aduhelm
“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as…
CapetivateJuly 13, 2021
Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs
June 29, 2021 This blogpost from a former FDA insider on the power of the…
CapetivateJune 29, 2021
FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003
Burlington, MA, June 7, 2021 - Today marks an important milestone in Alzheimer’s disease research with…
CapetivateJune 7, 2021
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
May 13, 2021 LuMind IDSC’s Chief Scientific Officer, James Hendrix, and a team of dedicated…
CapetivateMay 13, 2021
LuMind IDSC Supported the T21RS COVID-19 Initiative’s International Survey on Patients with COVID-19 and Down Syndrome
May 3, 2021 LuMind IDSC supported the T21RS COVID-19 Initiative that brought about the original…
CapetivateMay 3, 2021
Findings Released for Ongoing Study of Clinical Trial Participation by the Down Syndrome Community
March 9, 2021 (Burlington, MA): LuMind IDSC Foundation, the National Down Syndrome Society (NDSS), and…
CapetivateMarch 9, 2021
LuMind IDSC is Excited About a New Publication in the Journal of Patient-Reported Outcomes
As life expectancy of people with Down syndrome (DS) increases, so does the risk of…
CapetivateJanuary 15, 2021
